Data from Phase 1 Trial of Triplex Vaccine for Control of Cytomegalovirus Published in Blood
/
Date28 Oct 2016
Triplex Demonstrated Favorable Safety and Immunogenicity at Multiple Dose Levels in Healthy Volunteers Data Published in Blood Support Ongoing Phase 2 Trial of Triplex in... Read More →
Talyst to Exhibit at the LeadingAge Annual Meeting and Exposition
/
Date27 Oct 2016
KIRKLAND, Wash., Oct. 27, 2016 (GLOBE NEWSWIRE) — The Talyst Long-Term Care Division, a leader in automated medication management for skilled nursing facilities, will be... Read More →
Dr. Leonard B. Kobren Honored with the American College of Prosthodontists Education Foundation's Founders Society Award
/
Date27 Oct 2016
CHICAGO, Oct. 27, 2016 (GLOBE NEWSWIRE) — Leonard B. Kobren, DDS, was honored with the Founders Society Award by the American College of Prosthodontists (ACP)... Read More →
Dr. Leonard B. Kobren Honored with the American College of Prosthodontists Education Foundation's Founders Society Award
/
Date27 Oct 2016
CHICAGO, Oct. 27, 2016 (GLOBE NEWSWIRE) — Leonard B. Kobren, DDS, was honored with the Founders Society Award by the American College of Prosthodontists (ACP)... Read More →
Adaptimmune Announces Collaboration with MSD to Evaluate KEYTRUDA® (pembrolizumab) in Combination with NY-ESO SPEAR® T-Cell Therapy in Multiple Myeloma
/
Date27 Oct 2016
PHILADELPHIA and OXFORD, United Kingdom, Oct. 27, 2016 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced... Read More →
Hooper Holmes Selected by City of Olathe for Health Screening and Flu Vaccines
/
Date27 Oct 2016
OLATHE, Kan., Oct. 27, 2016 (GLOBE NEWSWIRE) — Hooper Holmes, Inc. (NYSE MKT:HH), a national leader in corporate wellness and health screenings is pleased to... Read More →
Adamas Submits New Drug Application to U.S. FDA for ADS-5102 for the Treatment of Levodopa-induced Dyskinesia in Patients with Parkinson’s Disease
/
Date27 Oct 2016
EMERYVILLE, Calif., Oct. 27, 2016 (GLOBE NEWSWIRE) — Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS), today announced that it has submitted a New Drug Application (NDA) to the... Read More →
TG Therapeutics, Inc. Announces Publication in Blood Describing a Novel Complimentary Mechanism of the PI3K-delta Inhibitor, TGR-1202
/
Date27 Oct 2016
Complimentary inhibition of PI3K-delta and casein kinase-1 (CK1) epsilon by TGR-1202 may provide mechanistic rationale for clinical activity in aggressive c-Myc driven lymphomas Publication outlines strong rationale for combining TGR-1202 and carfilzomib... Read More →
Global Vascular Stents Market will reach USD 4,230.0 Million by 2021
/
Date27 Oct 2016
Sarasota, FL, Oct. 27, 2016 (GLOBE NEWSWIRE) — Zion Research has published a new report titled “Vascular Stents Market (Fem-Pop Artery Stents, Iliac Artery Stents,... Read More →
MDxHealth Announces Positive Coverage Policy with Fourth-Largest Health Insurer in the United States
/
Date27 Oct 2016
IRVINE, Calif. and HERSTAL, Belgium, Oct. 27, 2016 (GLOBE NEWSWIRE) — MDxHealth SA (Euronext: MDXH.BR) today announced that Health Care Services Corporation (HCSC) has issued... Read More →